Method for expression of small antiviral rna molecules within a cell
CA 2457282 C · Owner: Baltimore, David · Inventors: Lois-Caballe, Carlos; Qin, Xiao-Feng; Baltimore, David
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
In ones aspect, the invention provides methods and compositions for the expression of small , RNA molecules within a cell using a retroviral vector. The methods can be used to express , double stranded RNA complexes. Small interfering RNA (siRNA) can be expressed using the , methods of the invention within a cell that interfere with a viral life cycle by down regulating , either the viral genome a viral genome transcript, or viral replication in a host cell. In another , aspect, the invention provides methods for treating patients suffering from infection, particularly , infection with HIV.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 13, 2002 and granted January 13, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 13, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 13, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.